Related Experiment Video
Updated: Jul 17, 2025

Detection and Visualization of DNA Damage-induced Protein Complexes in Suspension Cell Cultures Using the Proximity Ligation Assay
Published on: June 9, 2017
ATM-Mediated translocation of RanBPM regulates DNA damage response by stabilizing p21 in non-small cell lung cancer
Tanggang Deng1,2, Lin Xie3,4, Chen Xiaofang3
1Center for Clinical Precision Pharmacy, The First Affiliated Hospital, Guangdong Pharmaceutical University, 19 Nonglinxia Road, Yuexiu District, Guangzhou, Guangdong, China. dengtanggang@163.com.
Purpose:
Platinum-based chemotherapy remains a standard-of-care for most patients with advanced non-small cell lung cancer (NSCLC). DNA damage response (DDR) induced by platinum or Etoposide activated a panel of cell cycle-regulatory proteins including p21 through p53 pathway. Previous studies have reported that RanBPM has been involved in various cellular processes such as DDR by interacting with multiple proteins. However, the underlying mechanism remains unclear.
Methods:
NSCLC tissue microarrays were used for assessing the expression of RanBPM by immunohistochemical staining. The roles of RanBPM in the DDR of NSCLC progression was examined in in vitro cell lines and in vivo animal models. The regulation of RanBPM on protein stability and ubiquitination levels were investigated by immunoblots and in vivo ubiquitylation assay.
Results:
The level of p21 or RanBPM is lower in NSCLC than non-malignant tissues and has a highly positive correlation. Mechanistically, RanBPM protein physically interacts with p21, and RanBPM deubiquitinates p21 by recruiting a deubiquitinase USP11 to maintain protein stability of p21. RanBPM silencing significantly decreased p21 protein level. Conversely, RanBPM overexpression led to the accumulation of endogenous p21 protein regardless of p53 status. Functionally, RanBPM regulates DDR in a p21-dependent manner. Furthermore, DNA damage significantly promoted the nuclear translocation of RanBPM protein through ATM signaling pathways.
Conclusion:
RanBPM is a novel regulator of P21 protein stability, and plays a critical role in the regulation of DDR.
Insights
RanBPM stabilizes p21 protein, a key player in DNA damage response (DDR) in non-small cell lung cancer (NSCLC). This finding reveals RanBPM as a novel regulator critical for DDR in NSCLC progression.
Area of Science:
- Molecular Biology
- Oncology
- Cellular Biology
Background:
- Platinum-based chemotherapy is standard for advanced non-small cell lung cancer (NSCLC).
- DNA damage response (DDR) involves p53 pathway proteins like p21.
- RanBPM's role in DDR is known, but its mechanism is unclear.
Purpose of the Study:
- To elucidate the mechanism of RanBPM in regulating DNA damage response (DDR) in non-small cell lung cancer (NSCLC).
- To investigate the interaction between RanBPM and p21 in NSCLC.
- To determine the role of RanBPM in p21 protein stability and DDR.
Main Methods:
- Immunohistochemical staining of NSCLC tissue microarrays to assess RanBPM expression.
- In vitro and in vivo models to examine RanBPM's role in NSCLC DDR.
- Immunoblots and ubiquitylation assays to study RanBPM's regulation of protein stability.
Main Results:
- Lower levels of p21 and RanBPM in NSCLC tissues, with a positive correlation.
- RanBPM interacts with p21, recruiting USP11 to deubiquitinate and stabilize p21.
- RanBPM silencing decreased p21; overexpression increased p21, independent of p53 status.
- RanBPM regulates DDR in a p21-dependent manner; DNA damage promotes RanBPM nuclear translocation via ATM signaling.
Conclusions:
- RanBPM is a novel regulator of p21 protein stability.
- RanBPM plays a critical role in regulating DNA damage response (DDR).
Related Concept Videos
DNA Damage can Stall the Cell Cycle
Negative Regulator Molecules
Directionality of Nuclear Transport
Abnormal Proliferation
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
The Ras Gene
Ras is a...

